Otiro Capsule 40mg, manufactured by Bristol-Myers Squibb, contains Repotrectinib. This anti-cancer medication is used to treat certain non-small cell lung cancers and solid tumors, and is standardized as 40mg per capsule with a YJ code of 4291086M1025.
Otiro Capsule 40mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).